LIVE MARKET TRACKER :   BSE SENSEX   26851.05      |    NSE NIFTY 8014.55    
GLOBAL MARKETS :  NASDAQ 4483.715   +0.69%    |    FSI London 6388.73   -0.47%    |    NIKKEI Japan 15291.64   +1.01%
  USD GBP EUR CAD AUD INR
USD - 0.6217 0.7894 1.124 1.1374 61.285
GBP 1.6091 - 1.2703 1.8086 1.8302 98.6137
EUR 1.2672 0.7878 - 1.4243 1.4413 77.6616
CAD 0.8905 0.5536 0.703 - 1.0128 54.5745
AUD 0.8797 0.5469 0.6945 0.9888 - 53.913
INR 0.0163 0.0101 0.0129 0.0183 0.0186 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
RIL, Lupin and NMDC to see some action today
(22-Oct-2014)

RIL, Lupin and NMDC to see some action todayReliance Industries' (RIL) telecom arm - Reliance Jio Infocomm is merging its two subsidiaries, Infotel Telecom and Rancore Technologies, with itself. The move is aimed at bringing all its telecom related......click on news to read complete article.

ONGC, Hero MotoCorp and SAIL to see some action today
(21-Oct-2014)

ONGC, Hero MotoCorp and SAIL to see some action todayThe Government plans to offload a portion of its stake in ONGC by the first week of November. The move is expected to speed up the Government's disinvestment programme, which has been hanging fire for......click on news to read complete article.

RBI governor hopes the economy to grow by 5.5% this year
(17-Oct-2014)

RBI governor hopes the economy to grow by 5.5% this yearReserve Bank of India (RBI) governor Raghuram Rajan has expressed hopes on the Indian growth story and has said that the country is seeing a pick-up in economic growth and more can be done to support it......click on news to read complete article.

International Stock News
US markets close higher on Friday
(25-Oct-2014)

US markets close higher on FridayUS Markets ended higher on Friday after strong corporate results from Microsoft (MSFT) and Procter & Gamble (PG) and reduced concerns over the possible spread of Ebola. The shares of Microsoft......click on news to read complete article.

US markets close higher; S&P rallies for fourth day
(22-Oct-2014)

US markets close higher; S&P rallies for fourth dayThe US markets closed higher on Tuesday, delivering another day of gains for major indexes on the heels of upbeat quarterly results from tech giant Apple and talk of economic stimulus in Europe. By far......click on news to read complete article.

US markets close higher on optimism over corporate earnings
(21-Oct-2014)

US markets close higher on optimism over corporate earningsThe US markets closed higher on Monday, with equity investors beginning the week on positive note, as optimism over corporate earnings spurred a rebound from last week's selloff. That's two straight positive......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.